Travelzoo Reports First Quarter 2020 Results
NEW YORK, June 25, 2020 (GLOBE NEWSWIRE) — Travelzoo® (NASDAQ: TZOO):Revenue of $20.3 million, down from $29.2 million year-over-yearOperating loss […]
Golden Leaf Holdings Announces New Corporate Deck
TORONTO, June 25, 2020 (GLOBE NEWSWIRE) — Golden Leaf Holdings Ltd. (CSE:GLH) (OTCQB:GLDFF) (“Golden Leaf” or the “Company”), a premiere, […]
DHT Holdings, Inc. Business Update
HAMILTON, BERMUDA, June 25, 2020 – DHT Holdings, Inc. (NYSE:DHT) (“DHT” or the “Company”) today provides the following business update:Time […]
Outlook Therapeutics Announces Closing of $10.2 Million Financing Priced At-The-Market Under Nasdaq Rules
MONMOUTH JUNCTION, N.J., June 25, 2020 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK) (“the Company”), a late clinical-stage biopharmaceutical company working to […]
CRISPR Therapeutics Announces the Build-Out of New Cell Therapy Manufacturing Facility
-State-of-the-art facility to be located in Framingham, Massachusetts–-New facility intended to support clinical and commercial production of investigational cell therapies-ZUG, […]
AETERNA ZENTARIS ANNOUNCES DISTRIBUTION AGREEMENT WITH MEGAPHARM LTD. TO COMMERCIALIZE MACIMORELIN IN ISRAEL AND THE PALESTINE AUTHORITY
CHARLESTON, S.C, June 25, 2020 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ( the “Company”), a specialty biopharmaceutical […]
Tabula Rasa HealthCare® Expands Clinical Services for Patients Enrolled in Medicare Advantage
MOORESTOWN, N.J., June 25, 2020 (GLOBE NEWSWIRE) — Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing […]
Lyra Therapeutics Set to Join the Russell 2000® Index and Russell 3000® Index
WATERTOWN, Mass., June 25, 2020 (GLOBE NEWSWIRE) — Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the […]
Envision Added to the FTSE Russell Microcap Index
SAN DIEGO, June 25, 2020 (GLOBE NEWSWIRE) — Envision Solar International, Inc., (Nasdaq: EVSI, EVSIW) (“Envision Solar,” or the “Company”), […]
Celsion Affirms July Timing for Second Interim Analysis of the Phase III OPTIMA Study of ThermoDox® in Primary Liver Cancer
LAWRENCEVILLE, N.J, June 25, 2020 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN), an oncology drug-development company, today affirmed that the […]
